Covid-19 and intellectual property law: Compulsory licensing and the access to covid-19 treatment

Detalhes bibliográficos
Autor(a) principal: Oliveira, Anaísa Correia de
Data de Publicação: 2021
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10437/12203
Resumo: This essay concerns the problematic of the access to Covid-19 treatment at an international scale and the role of Intellectual Property Law. As in past public health outbreaks, one of the most raised questions is the possibility of patent holder’s rights being an obstacle to accessing treatment. Since the beginning of the pandemic, Compulsory Licensing has been presented as the Intellectual Property Law mechanism capable of guaranteeing Covid-19 treatment globally and effectively. We propose to analyse this figure and its possible alternatives: Voluntary Licensing, Patent Pools and the Proposal to waive TRIPS Intellectual Property provision. We will then assess which is the most effective solution to overcome this humanitarian crisis without compromising the balance between the right to health and intellectual property rights.
id RCAP_4a333c7c1525d933b90e5fe816088d8a
oai_identifier_str oai:recil.ensinolusofona.pt:10437/12203
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str
spelling Covid-19 and intellectual property law: Compulsory licensing and the access to covid-19 treatmentDIREITOPROPRIEDADE INTELECTUALPATENTESACORDO TRIPSLAWCOVID-19INTELLECTUAL PROPERTYPATENTSAGREEMENT ON TRADE-RELATED ASPECTS OF INTELLECTUAL PROPERTY RIGHTSThis essay concerns the problematic of the access to Covid-19 treatment at an international scale and the role of Intellectual Property Law. As in past public health outbreaks, one of the most raised questions is the possibility of patent holder’s rights being an obstacle to accessing treatment. Since the beginning of the pandemic, Compulsory Licensing has been presented as the Intellectual Property Law mechanism capable of guaranteeing Covid-19 treatment globally and effectively. We propose to analyse this figure and its possible alternatives: Voluntary Licensing, Patent Pools and the Proposal to waive TRIPS Intellectual Property provision. We will then assess which is the most effective solution to overcome this humanitarian crisis without compromising the balance between the right to health and intellectual property rights.O presente artigo incide sobre a problemática existente entre o acesso ao tratamento da COVID-19 e o Direito de Propriedade Intelectual a nível internacional. Tal como em epidemias anteriores, uma das questões mais debatidas é a possibilidade dos direitos dos inventores constituírem um obstáculo ao acesso ao tratamento. Desde o início desta pandemia, as Licenças Compulsórias foram apresentadas como o mecanismo capaz de garantir esse acesso de forma rápida e universal. Neste artigo propomo-nos a analisar esta figura legal e possíveis meios alternativos: Licenças Voluntárias, Patent Pools e até o Pedido de suspensão do Regime de Propriedade Intelectual do Acordo TRIPS. Após uma comparação, tentaremos desvendar qual a solução mais eficaz para se alcançar o fim desta crise humanitária sem colocar em causa o equilíbrio entre o direito à saúde e os direitos de propriedade intelectual.Edições Universitárias Lusófonas2021-10-15T10:51:47Z2021-01-01T00:00:00Z2021info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10437/12203eng2182-5912Oliveira, Anaísa Correia deinfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-03-09T14:09:31ZPortal AgregadorONG
dc.title.none.fl_str_mv Covid-19 and intellectual property law: Compulsory licensing and the access to covid-19 treatment
title Covid-19 and intellectual property law: Compulsory licensing and the access to covid-19 treatment
spellingShingle Covid-19 and intellectual property law: Compulsory licensing and the access to covid-19 treatment
Oliveira, Anaísa Correia de
DIREITO
PROPRIEDADE INTELECTUAL
PATENTES
ACORDO TRIPS
LAW
COVID-19
INTELLECTUAL PROPERTY
PATENTS
AGREEMENT ON TRADE-RELATED ASPECTS OF INTELLECTUAL PROPERTY RIGHTS
title_short Covid-19 and intellectual property law: Compulsory licensing and the access to covid-19 treatment
title_full Covid-19 and intellectual property law: Compulsory licensing and the access to covid-19 treatment
title_fullStr Covid-19 and intellectual property law: Compulsory licensing and the access to covid-19 treatment
title_full_unstemmed Covid-19 and intellectual property law: Compulsory licensing and the access to covid-19 treatment
title_sort Covid-19 and intellectual property law: Compulsory licensing and the access to covid-19 treatment
author Oliveira, Anaísa Correia de
author_facet Oliveira, Anaísa Correia de
author_role author
dc.contributor.author.fl_str_mv Oliveira, Anaísa Correia de
dc.subject.por.fl_str_mv DIREITO
PROPRIEDADE INTELECTUAL
PATENTES
ACORDO TRIPS
LAW
COVID-19
INTELLECTUAL PROPERTY
PATENTS
AGREEMENT ON TRADE-RELATED ASPECTS OF INTELLECTUAL PROPERTY RIGHTS
topic DIREITO
PROPRIEDADE INTELECTUAL
PATENTES
ACORDO TRIPS
LAW
COVID-19
INTELLECTUAL PROPERTY
PATENTS
AGREEMENT ON TRADE-RELATED ASPECTS OF INTELLECTUAL PROPERTY RIGHTS
description This essay concerns the problematic of the access to Covid-19 treatment at an international scale and the role of Intellectual Property Law. As in past public health outbreaks, one of the most raised questions is the possibility of patent holder’s rights being an obstacle to accessing treatment. Since the beginning of the pandemic, Compulsory Licensing has been presented as the Intellectual Property Law mechanism capable of guaranteeing Covid-19 treatment globally and effectively. We propose to analyse this figure and its possible alternatives: Voluntary Licensing, Patent Pools and the Proposal to waive TRIPS Intellectual Property provision. We will then assess which is the most effective solution to overcome this humanitarian crisis without compromising the balance between the right to health and intellectual property rights.
publishDate 2021
dc.date.none.fl_str_mv 2021-10-15T10:51:47Z
2021-01-01T00:00:00Z
2021
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10437/12203
url http://hdl.handle.net/10437/12203
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 2182-5912
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Edições Universitárias Lusófonas
publisher.none.fl_str_mv Edições Universitárias Lusófonas
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1777302248307556353